Qrativ

Qrativ Combines nference's AI-based Knowledge Synthesis Platform with Mayo Clinic’s Medical Expertise and Clinical Data to Develop the Drug Therapy Platform Darwin.ai. This platform supports systematic drug discovery, especially for new drug development targeting rare diseases. Partners of Qrativ can leverage the Darwin.ai platform to explore all potential uses of candidate drugs, including identifying potential indications for rare diseases and finding the patient subgroups most likely to benefit from a given drug candidate.